Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01 recall — FDA D-0492-2024
Discoloration: Dotted and yellow spots on tablets
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Discoloration: Dotted and yellow spots on tablets
Out of specification for assay
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
BMW of North America, LLC (BMW) is recalling certain 2024 XM, 2025 BMW X5 sDrive40i, X5 xDrive40i, X5 M60i, X5 M, X5 xDrive50e, X6 xDrive40i, X6 M60i, X6 M, X7 xDrive40i, X7 M60i, and…
Ford Motor Company (Ford) is recalling certain 2022-2024 Maverick, 2020-2022 Escape, and 2021-2022 Lincoln Corsair vehicles. The Hybrid Powertrain Control Module (HPCM) software may cause…
BMW of North America, LLC (BMW) is recalling certain 2024-2025 X5 xDrive40i vehicles. The tire information placard may indicate an incorrect tire size and tire pressure. As such, these…
Ford Motor Company (Ford) is recalling certain 2024 F-150 vehicles. The steering column lower shaft may have been secured to the steering gear assembly with an incorrect fastener, which can…
Lack of Assurance of Sterility: Complaints of syringe breakage
Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
Labeling: Wrong Barcode
Hyundai Motor America (Hyundai) is recalling certain 2024 Elantra, Venue, and Kona vehicles. An electrical short circuit may occur in the exhaust gas recirculation (EGR) valve assembly,…
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified…
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified…
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified…
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified…
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making…
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Nissan North America, Inc. (Nissan) is recalling certain 2024 Sentra vehicles. The front left-side driveshaft may not be fully seated in the continuously variable transmission (CVT)…
Browse recent months with enough recall history for useful comparison.